Probing the use of fluorescence spectroscopy as a novel diagnostic tool in patients with rheumatoid arthritis: applicability in the detection of secondary amyloidosis.
Abstract
BACKGROUND
Secondary amyloidosis is a frequently reported complication of rheumatoid arthritis. Currently, accepted diagnostic protocols
for secondary amyloidosis involve histopathological and histochemical examinations of collected tissue specimens. The purpose
of the current report was to evaluate the value of fluorescence spectroscopy as a supplementary tool in the diagnosis of secondary
amyloidosis.
MATERIAL/METHODS
Tissue specimens were collected from abdominal folds, gingiva or rectal mucosa of 99 patients affected with rheumatoid arthritis.
Tissue samples were subjected to preliminary clinical observations, histopathological examinations and laboratory tests. These
procedures were used to subdivide tissue samples into either amyloid-containing or amyloid-free control subgroups. All collected
tissue samples were examined with the use of a designated spectrofluorometer and fluorescence spectral images were generated.
RESULTS
It was found that fluorescence spectra for amyloid-containing tissues were typically characterized by a double emittance peak.
In contrast, amyloid-free samples were characterized by fluorescence spectra with a single λmax value. Specimen collection
site, age and sex did not appear to influence the morphology of electromagnetic spectra, which were generated for both amyloid-containing
and amyloid-free tissue samples. The sensitivity of the fluorometric approach was ~78% and the specificity was 100%. Possible
shortcomings of the technique may be due to the limit of detection of the instrument used.
CONCLUSIONS
Fluorescence spectroscopy may potentially be used as an effective, instantaneous and low-cost diagnostic tool for suspected
secondary amyloidosis in patients affected with rheumatoid arthritis.
Links
Authors
Jeka S, Zuchowski P, Korkosz M, Prochorec-Sobieszek M, Fisz JJ
Institution
Clinical Department of Rheumatology and Connective Tissue Diseases, University Hospital No 2 Dr. Jan Biziel, Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Torun, Bydgoszcz, Poland. kakita@op.pl
Source
Medical science monitor : international medical journal of experimental and clinical research 18:10 2012 Oct pg BR414-8MeSH
AdultAged
Amyloidosis
Arthritis, Rheumatoid
Case-Control Studies
Diagnostic Techniques and Procedures
Female
Humans
Male
Middle Aged
Spectrometry, Fluorescence
Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
23018349
Log In

